Silverback Therapeutics, Inc.
Silverback Therapeutics, Inc. (SBTX) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 43 transactions totaling $58.5M, demonstrating a bullish sentiment with $58.5M in net insider flow. The most recent transaction on Aug 5, 2022 involved a transaction of 78,740 shares valued at $100.0K.
SBTX Insider Activity Summary
Who Is Buying SBTX Stock?
No significant insider buying has been recorded for SBTX in the recent period.
Who Is Selling SBTX Stock?
No significant insider selling has been recorded for SBTX in the recent period.
Is Silverback Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SBTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $58.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SBTX Frequently Asked Questions
Understanding SBTX Insider Activity
Insider trading at Silverback Therapeutics, Inc. (SBTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading SBTX stock, having executed 43 transactions in the past 90 days. The most active insider is Capital Llc Orbimed (Executive), who has made 5 transactions totaling $25.0M.
Related Tools
Track Silverback Therapeutics, Inc. Insider Activity
Get notified when executives and directors at SBTX file new Form 4 transactions